Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Hepatitis C Virus Genotype 1”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT01033448
What this trial is testing

Extended Therapy of PEGASYS (Peginterferon Alfa-2a) in Combination With COPEGUS (Ribavirin) in Patients With Chronic Hepatitis C and Slow Response

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 59
Testing effectiveness (Phase 2)Study completedNCT01271790
What this trial is testing

Response-Guided Duration of Combination Therapy With GS-9451, Pegasys® and Copegus® With and Without Tegobuvir (GS-9190) in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C

Who this might be right for
Hepatitis C, Chronic
Gilead Sciences 245
Not applicableNo Longer AvailableNCT01508286
What this trial is testing

Early Access Program of Telaprevir With Peginterferon and Ribavirin in Chronic Hepatitis C Subjects

Who this might be right for
Hepatitis C
Janssen-Cilag International NV
Large-scale testing (Phase 3)Study completedNCT01571583
What this trial is testing

An Efficacy and Safety Study of Telaprevir in Patients With Genotype 1 Hepatitis C Infection After Liver Transplantation

Who this might be right for
Chronic Hepatitis C Virus (HCV) Infection
Janssen-Cilag International NV 74
Large-scale testing (Phase 3)Study completedNCT02651194
What this trial is testing

Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Renally Impaired Adults With Chronic Hepatitis C Virus Genotype 1 - 6 Infection

Who this might be right for
Chronic Hepatitis C Virus (HCV) Infection
AbbVie 104
Testing effectiveness (Phase 2)Study completedNCT01054729
What this trial is testing

Dose-Ranging Study of Sofosbuvir in Combination With Pegylated Interferon and Ribavirin in Treatment Naïve GT 1 HCV Patients

Who this might be right for
Hepatitis C
Gilead Sciences 64
Post-approval studies (Phase 4)WithdrawnNCT02206932
What this trial is testing

The Safety and Effectiveness of Simeprevir and Sofosbuvir for Patients With HIV and Hepatitis C

Who this might be right for
Hepatitis C, ChronicHIV CDC Category A1
University of California, San Francisco
Testing effectiveness (Phase 2)Study completedNCT01221298
What this trial is testing

A Pilot Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of ABT-450 With Ritonavir (ABT-450/r) Dosed in Combination With ABT-072 and Ribavirin (RBV)

Who this might be right for
Hepatitis CHCVChronic Hepatitis C Infection+1 more
AbbVie (prior sponsor, Abbott) 11
Testing effectiveness (Phase 2)Study completedNCT02262728
What this trial is testing

An Efficacy, Safety and Pharmacokinetics Study of Simeprevir, Daclatasvir and Sofosbuvir in Participants With Chronic Hepatitis C Virus Genotype 1 or 4 Infection and Decompensated Liver Disease

Who this might be right for
Hepatitis C, Chronic
Janssen Research & Development, LLC 40
Large-scale testing (Phase 3)Study completedNCT01288209
What this trial is testing

A Phase III Study of TMC435 in Genotype 1, Hepatitis C-infected Participants Who Failed to Respond to Previous IFN-based Therapy

Who this might be right for
Hepatitis C, Chronic
Janssen Pharmaceutical K.K. 106
Testing effectiveness (Phase 2)Study completedNCT01353911
What this trial is testing

Grazoprevir (MK-5172) Administered With Peginterferon and Ribavirin in Treatment-Naïve Participants With Chronic Hepatitis C (MK-5172-003)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 368
Large-scale testing (Phase 3)Study completedNCT01701401
What this trial is testing

Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination (FDC) With and Without Ribavirin for the Treatment of HCV

Who this might be right for
Chronic Hepatitis C Virus
Gilead Sciences 870
Testing effectiveness (Phase 2)Study completedNCT00537407
What this trial is testing

Debio 025 in Combination With PegIFN Alpha-2a and Ribavirin in Chronic HCV Patients Non-responders to Standard Treatment

Who this might be right for
Chronic Hepatitis C
Debiopharm International SA 50
Testing effectiveness (Phase 2)Study completedNCT00869661
What this trial is testing

RO5024048 in Combination With Pegasys and Copegus in Treatment-Naive Patients With Chronic Hepatitis C, Genotype 1 or 4

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 413
Large-scale testing (Phase 3)Study completedNCT01754974
What this trial is testing

Safety and Efficacy Study of Peginterferon Lambda-1a vs. Peginterferon Alfa-2a, Plus Ribavirin in Subjects With Genotype 1 Hepatitis C

Who this might be right for
Hepatitis C Virus (HCV)
Bristol-Myers Squibb 40
Early research (Phase 1)Study completedNCT01523990
What this trial is testing

Evaluate the Safety, Tolerability, and PK in Healthy Volunteers and HCV Genotype 1 Infected Patients

Who this might be right for
HealthyHepatitis C, Chronic
TaiGen Biotechnology Co., Ltd. 135
Large-scale testing (Phase 3)Study completedNCT01573351
What this trial is testing

Phase III Hallmark QUAD: ASV+DCV+Peg+Rib (Nulls/Partials)

Who this might be right for
Hepatitis C Virus
Bristol-Myers Squibb 398
Not applicableStudy completedNCT01884402
What this trial is testing

Observational,Prospective Study to Develop and Validate a Prognostic Tool to Optimize Therapy in Patients With HCV G1/4

Who this might be right for
Hepatitis C, Chronic
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 770
Large-scale testing (Phase 3)Study completedNCT03212521
What this trial is testing

Efficacy and Safety of 8-weeks of Glecaprevir/Pibrentasvir in Treatment-Naïve Adults With HCV Genotype 1-6 and Aspartate Aminotransferase to Platelet Ratio Index (APRI) ≤1

Who this might be right for
Hepatitis C Virus (HCV)
AbbVie 230
Large-scale testing (Phase 3)Study completedNCT02207088
What this trial is testing

Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Ribavirin in HCV Genotype 1-Infected Adults With Chronic Kidney Disease

Who this might be right for
Chronic Hepatitis CHepatitis C VirusCompensated Cirrhosis+2 more
AbbVie 68
Next Page